Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Spinolo

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Bone Marrow Transplantation|April 1, 1990
Methylprednisolone, cyclosporine and methotrexate for prophylaxis of acute graft-versus-host diseaseJ C Yau, C F LeMaistre, G K Zagars, et al.
American Journal of Hematology|September 1, 1992
Allogeneic bone marrow transplantation for hematological malignancies following etoposide, cyclophosphamide, and fractionated total body irradiationJ C Yau, C F LeMaistre, B S Andersson, et al.
American Journal of Hematology|June 1, 1994
Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiationM A Dimopoulos, J C Yau, S D Huan, et al.
Bone Marrow Transplantation|April 1, 1990
High dose cyclophosphamide, BCNU and VP-16 with autologous blood stem cell support for refractory multiple myelomaG J Ventura, B Barlogie, J P Hester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignanciesM R Bishop, P L Iversen, E Bayever, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Bone Marrow Transplantation|April 1, 1990
Methylprednisolone, cyclosporine and methotrexate for prophylaxis of acute graft-versus-host diseaseJ C Yau, C F LeMaistre, G K Zagars, et al.
American Journal of Hematology|September 1, 1992
Allogeneic bone marrow transplantation for hematological malignancies following etoposide, cyclophosphamide, and fractionated total body irradiationJ C Yau, C F LeMaistre, B S Andersson, et al.
American Journal of Hematology|June 1, 1994
Allogeneic bone marrow transplantation for leukemia following piperazinedione and fractionated total body irradiationM A Dimopoulos, J C Yau, S D Huan, et al.
Bone Marrow Transplantation|April 1, 1990
High dose cyclophosphamide, BCNU and VP-16 with autologous blood stem cell support for refractory multiple myelomaG J Ventura, B Barlogie, J P Hester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignanciesM R Bishop, P L Iversen, E Bayever, et al.
Pageof 6